Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II

Int J Neuropsychopharmacol. 2017 Mar 1;20(3):281-284. doi: 10.1093/ijnp/pyw092.

Authors

Ross J Baldessarini¹, Wai K Lau¹, Jordan Sim¹, Min Y Sum¹, Kang Sim¹

Affiliation

¹ International Consortium for Research on Psychotic and Mood Disorders, Mailman Research Center, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts; Research Department and Department of General Psychiatry, Institute of Mental Health, Singapore.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antidepressive Agents*
Depressive Disorder, Major*
Humans
Suicide
Violence

Substances

Antidepressive Agents